Tetraphase’s (NASDAQ:TTPH) Auryxia just won the Food and Drug Administration (FDA) green light for treating patients with complicated Intra-Abdominal Infections (cIAI), but Needham’s Alan Carr believes …
Tetraphase (NASDAQ:TTPH) investors are scratching their heads today as to why the stock is falling 8% following the announcement of FDA approval for …
H.C.
A handful of bio-pharmaceutical stocks are announcing their financial results for the final quarter of 2014 this week. What should investors watch for?
